2010
Time: The Crucial Fourth Dimension of Personalized Medicine
During the U.S. healthcare deliberations, the words invention, technology, diagnostics, and wellness were mentioned rarely, if ever. No one said “revolution in healthcare” and yet a healthcare revolution is underway. Never before could a physician peer into the body, blood, or DNA of a patient and “see” the risk of disease for that person or “see” a disease at such an early stage that intervention might be crucial. That vision defines personalized medicine, which includes actionable measurements of genotype and phenotype – DNA and proteins.
For the inaugural symposium, Gold Lab invited medical and scientific thought leaders and stakeholders to debate and inform each other and the audience on how best to facilitate the most timely transformation of medicine. “Our motivation is simple,” said Dr. Larry Gold, Professor, MCDB, University of Colorado and CEO of SomaLogic, “Scientists are responsible for innovations; scientists also must participate in discussions that enable the timely use of those innovations. An informed citizenry is at the heart of an improved healthcare system.”
-
-
Opening Remarks 2010
Larry Gold serves as the Founder and Chairman of the Board of SomaLogic, and is a Professor at the University of Colorado Boulder.
-
-
Personalized Medicine Technologies: Omics for Everyone
-
Human Genetics and Disease
Dr. Richard A. Spritz is Professor of Pediatrics and Director of the Human Medical Genetics Program at the University of Colorado School of Medicine.
-
Protein Biomarkers: A Blood Test for Early Stage Non Small Cell Lung Cancer
William N. Rom M.D., MPH is the Sol and Judith Professor of Medicine and Environmental Medicine at New York University School of Medicine and Director of the Division of Pulmonary and Critical Care Medicine.
-
Monitoring Wellness: Blood Tests for Many Diseases
Dr. Williams trained as a physician at Charing Cross and Westminster medical school, University of London, and following his internships returned to the same institution for a Ph.D. in medicine and physiology.
-
Time: Personalized Medicine’s Final Frontier
Fintan Steele joined SomaLogic in 2011 as executive director for communications. Fintan's background includes more than 20 years of experience in communicating scientific research, particular the science (and its implications) behind the "omics revolution."
-
-
Diagnostic Information, Connectedness, and Drugs: Systems Infrastructures
-
Sustaining Healthcare Innovation in an Era of Constraint
Dr. George Poste is Chief Scientist, Complex Adaptive Systems Initiative (CASI) at Arizona State University. This program links expertise across the university in research on synthetic biology, ubiquitous sensing and Healthcare informatics for personalized medicine.
-
Diagnostics in the Reference Labs: Putting the Patient First
Dr. Wohlgemuth is Vice President of Science & Innovation of the Quest Diagnostics Nichols Institute in San Juan Capistrano, CA.
-
The Healthcare Ecosystem: Connecting the Parts
Donald Jones serves as vice president of business development for Qualcomm Incorporated. He is responsible for leading Qualcomm’s expansion of wireless technologies into the consumer health, healthcare and medical device markets.
-
Improved Interventions: Drug Use and Best Practices
As Medco’s Chairman and Chief Executive Officer, David B. Snow, Jr., architected the transformation of Medco Health Solutions into an enterprise that is today recognized as one of the world’s most admired and innovative companies, and a leader in clinically driven pharmacy care that empowers the practice of precision medicine.
-
A guided discussion with panelists led by Tom Cech
Dr. Cech was raised and educated in Iowa (B.A. in chemistry from Grinnell College, 1970). He obtained his Ph.D. in chemistry from the University of California, Berkeley.
-
-
Perspectives: Challenges to Change
-
Patient-Centered Care Perspectives: Views from Where We Stand, Sit, and Lie Down
Scott Danielson is a tinkerer, inventor and entrepreneur who creates high-impact, high-value, customer-centered products and services.
-
Pathway-Specific Medicines: 21st Century Solutions to Unmet Medical Needs
Larry is an expert in biotechnology, a field that he has worked in commercially for over 27 years. In 1981, he was a founding scientist of Genetics Institute (acquired by Wyeth), one of the earliest biotechnology companies.
-
The Parent Project: Advocating for Children’s Health
Pat Furlong is the Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non profit organization in the United States solely focused on Duchenne muscular dystrophy (Duchenne).
-
The Gardasil Story: A Vaccine to Prevent Cervical Cancer
Keith Gottesdiener, M.D., is Chief Executive Officer of Rhythm Pharmaceuticals, Inc., a Boston based biotech company that specializes in the development of peptide therapeutics for the treatment of metabolic diseases, such as diabetes, obesity and functional GI disorders.
-
-
Societal Dimensions: Healthcare in the Promised Land
-
A New Moral Vision for Health Care
Denver. Richard D. Lamm is one of the new breed of policy analysts who argues that the challenge of the 21st century is to meet new public needs by reconceptualizing much of what government does and how it does it.
-
Personalized Medicine: Facilitating a Partnership with the FDA
Daniel Kracov is a Partner and Head of the FDA and Healthcare Regulatory Practice Group at Arnold & Porter LLP.
-
New World. New Doctors. New Training
David Rosenman is a hospital-based physician at the Mayo Clinic in Rochester, Minnesota. At the Mayo Medical School, David's pride and joy is the Preclinical Block, a six-week, multidisciplinary transition from the classroom to the real world
-
Growing Pains: The Evolution Toward Consumer-Driven Medicine
Dr. Lawrence served as CEO and Chairman of Kaiser Foundation Health Plan and Hospitals until his retirement in 2002. He was appointed CEO in 1991 and Chairman the next year.
-
-
Closing Remarks
-
Closing Remarks 2010
Larry Gold serves as the Founder and Chairman of the Board of SomaLogic, and is a Professor at the University of Colorado Boulder.
-
Contact Info
Gold Lab
University of Colorado Boulder
347 UCB Boulder, CO 80309Tel: (303) 735-7112
Email: info@goldlabfoundation.org
